Literature DB >> 32096213

Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children.

Sif Gudbrandsdottir1,2,3, Emily Leven1,4, Allison Imahiyerobo1,5, Christina Soo Lee1,6, James Bussel1.   

Abstract

Entities:  

Keywords:  immunosuppressants; intravenous immunoglobulin G; primary immune thrombocytopenia; refractory disease; thrombopoietin-receptor agonists

Mesh：

Substances：

Year:  2020        PMID： 32096213     DOI： 10.1111/bjh.16426

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Evolving treatment modalities for immune thrombocytopenia in adults.

Authors:  Sushmita Khadka; Vineela Kasireddy; Pravash Kumar Dhakal; Chandrakala Dadiboyina
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-01-26

Review 2.  Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.

Authors:  Nicola Vianelli; Giuseppe Auteri; Francesco Buccisano; Valentina Carrai; Erminia Baldacci; Cristina Clissa; Daniela Bartoletti; Gaetano Giuffrida; Domenico Magro; Elena Rivolti; Daniela Esposito; Gian Marco Podda; Francesca Palandri
Journal:  Ann Hematol       Date:  2022-02-24       Impact factor: 4.030

3.  Avatrombopag Effectively Maintained Platelet Counts in a Patient with Immune Thrombocytopenia Who Was Intolerant to Tyrosine Kinase Inhibitor Therapy.

Authors:  Hillary S Maitland
Journal:  Am J Case Rep       Date:  2021-12-04

Review 4.  Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?

Authors:  Yue Lv; Huiping Shi; Hong Liu; Lu Zhou
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

5.  [Prospects of individualized diagnosis and treatment of primary immune thrombocytopenia in the era of new drugs].

Authors:  L L Huang; H Mei
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.